在四名先前接受治疗的甲型血友病患者中引入缺失B结构域的重组凝血因子VIII后凝血因子VIII抑制剂的产生情况。 - Suppr

Suppr

超能文献

Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients.

作者信息

Roussel-Robert V, Torchet M F, Legrand F, Rothschild C, Stieltjes N

出版信息

J Thromb Haemost. 2003 Nov;1(11):2450-1. doi: 10.1046/j.1538-7836.2003.0468a.x.

DOI:10.1046/j.1538-7836.2003.0468a.x

PMID:14629482

Abstract

摘要

相似文献

Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients.在四名先前接受治疗的甲型血友病患者中引入缺失B结构域的重组凝血因子VIII后凝血因子VIII抑制剂的产生情况。

J Thromb Haemost. 2003 Nov;1(11):2450-1. doi: 10.1046/j.1538-7836.2003.0468a.x.

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison.从全长因子VIII主要转换为B结构域缺失的因子VIII后，重度A型血友病患者中因子VIII抑制剂的发生率：一项前瞻性队列比较。

Haemophilia. 2015 Mar;21(2):219-226. doi: 10.1111/hae.12563. Epub 2014 Nov 7.

Risk of inhibitors in previously untreated patients with hemophilia: a meta-analysis of literature studies.既往未经治疗的血友病患者中出现抑制物的风险：文献研究的荟萃分析

Blood. 2015 Jun 11;125(24):3819-21. doi: 10.1182/blood-2015-01-621383.

Comparative immunogenicity of recombinant B domain-deleted porcine factor VIII and Hyate:C in hemophilia A mice presensitized to human factor VIII.重组B结构域缺失猪源因子VIII与Hyate:C在对人源因子VIII致敏的甲型血友病小鼠中的免疫原性比较

J Thromb Haemost. 2004 Apr;2(4):605-11. doi: 10.1111/j.1538-7836.2004.00685.x.

The management of hemophilia patients with inhibitors.血友病抑制物患者的管理

Transfus Med Rev. 1992 Oct;6(4):285-93. doi: 10.1016/s0887-7963(92)70185-0.

Factor VIII brand and immunogenicity.凝血因子VIII品牌与免疫原性。

Blood. 2014 Nov 27;124(23):3337-8. doi: 10.1182/blood-2014-10-604991.

More on: mild hemophilia A and inhibitor development.更多内容：轻度甲型血友病与抑制物的形成。

J Thromb Haemost. 2004 Apr;2(4):676; author reply 677. doi: 10.1111/j.1538-7836.2004.00677.x.

The use of agents that by-pass factor VIII inhibitors in patients with haemophilia.在血友病患者中使用绕过凝血因子VIII抑制剂的药物。

Vox Sang. 1999;77 Suppl 1:38-41. doi: 10.1159/000056714.

Suggestions for the management of factor VIII inhibitors.关于VIII因子抑制剂管理的建议。

Haemophilia. 2000 Jul;6 Suppl 1:52-9.

Inhibitor development in prospective clinical trials with recombinant factor VIII preparations in previously untreated patients.在既往未接受治疗的患者中使用重组凝血因子VIII制剂进行前瞻性临床试验时的抑制剂开发。

Vox Sang. 1999;77 Suppl 1:9. doi: 10.1159/000056705.

引用本文的文献

The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program.沙特血友病患者中凝血因子VIII和IX抑制剂的患病率：沙特全国血友病筛查项目的结果。

Medicine (Baltimore). 2017 Jan;96(2):e5456. doi: 10.1097/MD.0000000000005456.

Switching treatments in haemophilia: is there a risk of inhibitor development?血友病治疗的转换：是否存在产生抑制物的风险？

Eur J Haematol. 2015 Apr;94(4):284-9. doi: 10.1111/ejh.12433. Epub 2014 Sep 17.

Long-term efficacy and safety of a pasteurized, plasma-derived factor VIII concentrate (Beriate® P) in patients with haemophilia A.一种经巴氏消毒的血浆源性凝血因子VIII浓缩物（Beriate® P）在甲型血友病患者中的长期疗效和安全性。

Thromb Res. 2014 Nov;134 Suppl 1:S38-42. doi: 10.1016/j.thromres.2013.10.015. Epub 2013 Nov 17.

Inhibitors in previously treated patients: a review of the literature.既往治疗患者的抑制剂：文献复习。

Haemophilia. 2010 May;16(102):61-5. doi: 10.1111/j.1365-2516.2010.02235.x.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验